You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国同辐(01763.HK):原子高科拟发行不超过3210万股
格隆汇 08-30 21:31

格隆汇8月30日丨中国同辐(01763.HK)旗下一間上市附屬公司原子高科(430005)公布定增方案,为稳固及加大公司在核医药业务的拓展力度、加大公司核医药产品产能、加快医药中心产业布局,全力巩固公司在核医药产业的优势及核心竞争力,增强公司的盈利能力和抗风险能力,保障公司可持续发展需要,拟实施此次股票发行工作,发行募集资金将用于公司分子靶向诊疗药品研发生产基地建设、医药中心新建和扩建项目及补充公司日常流动资金。

拟发行股票数量不超过3210万股,股票发行价格为21.00元/股,募集资金总额不超过67410万元人民币。发行对象为截止股权登记日公司全体在册股东(近700人)。公司全体股东均有权按照其持有的公司股份数额同比例认购,本次发行股票不会新增股东。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account